Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF

10 Oct 2018

Abstract excerpt

BACKGROUND: Therapies targeting certain CFTR mutants have been approved, yet variations in clinical response highlight the need for in-vitro and genetic tools that predict patient-specific clinical outcomes. Toward this goal, the CF Canada-Sick Kids Program in Individual CF Therapy (CFIT) is generating a "first of its kind", comprehensive resource containing patient-specific cell cultures and data from 100 CF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Ear and Nasal Anomalies
Share to Cystic Fibrosis Research Advances
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29685812
DOI: 10.1016/j.jcf.2018.03.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CFPMID 29685812Read ↗

Personalized medicine for cystic fibrosis: establishing human model systems.Semantic proximity Read ↗

Precision medicine advances in cystic fibrosis: Exploring genetic pathways for targeted therapies.Semantic proximity Read ↗

INTEGRATING GENOMIC AND FUNCTIONAL TESTING TO IMPROVE CFTR MODULATOR RESPONSE PREDICTION IN CHILDREN WITH CYSTIC FIBROSISSemantic proximity Read ↗

A new platform for high-throughput therapy testing on iPSC-derived, immature airway from Cystic Fibrosis PatientsSemantic proximity Read ↗

Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic ManagementSemantic proximity Read ↗

A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients.Semantic proximity Read ↗

A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptomsSemantic proximity Read ↗

Analysis of the Genome Aggregation Database (gnomAD) reveals a global burden of cystic fibrosis and the need for improved diagnosis and care.Semantic proximity Read ↗

Development of novel therapeutics for all individuals with CF (the future goes on).Semantic proximity Read ↗

Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells.Semantic proximity Read ↗

Personalized or Precision Medicine? The Example of Cystic FibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.